SEARCH

SEARCH BY CITATION

Abstract

  1. Top of page
  2. Abstract
  3. Materials and Methods
  4. Results
  5. Discussion
  6. References
  7. Supporting Information

In this study, we determined the role of the nuclear factor-kappaB (NF-κB) subunit c-Rel in liver injury and regeneration. In response to toxic injury of the liver, c-Rel null (c-rel−/−) mice displayed a defect in the neutrophilic inflammatory response, associated with impaired induction of RANTES (Regulated upon Activation, Normal T-cell Expressed, and Secreted; also known as CCL5). The subsequent fibrogenic/wound-healing response to both chronic carbon tetrachloride and bile duct ligation induced injury was also impaired and this was associated with deficiencies in the expression of fibrogenic genes, collagen I and α-smooth muscle actin, by hepatic stellate cells. We additionally report that c-Rel is required for the normal proliferative regeneration of hepatocytes in response to toxic injury and partial hepatectomy. Absence of c-Rel was associated with blunted and delayed induction of forkhead box M1 (FoxM1) and its downstream targets cyclin B1 and Cdc25C. Furthermore, isolated c-rel−/− hepatocytes expressed reduced levels of FoxM1 and a reduced rate of basal and epidermal growth factor–induced DNA synthesis. Chromatin immunoprecipitation revealed that c-Rel binding to the FoxM1 promoter is induced in the regenerating liver. Conclusion: c-Rel has multiple functions in the control of liver homeostasis and regeneration and is a transcriptional regulator of FoxM1 and compensatory hepatocyte proliferation. (HEPATOLOGY 2010.)

Nuclear factor-kappaB (NF-κB) is a regulator of hepatic inflammation, wound-healing, regeneration, and carcinogenesis.1, 2 These functions reflect the ability of NF-κB to stimulate expression of cytokines, chemokines, growth factors, and regulators of apoptosis and cell proliferation.3 The classic NF-κB activation pathway is induced in response to a variety of stimuli including inflammatory mediators and microbial or host ligands of the Toll-like receptor system. In response to these stimuli the inhibitor of NF-κB (IκB) kinase (IKK) complex (IKK1, IKK2, and NEMO [NF-κB essential modifier]) is activated, leading to phosphorylation of the inhibitor IκBα and subsequent nuclear transport of active NF-κB.1–3 Most studies of hepatic NF-κB have focused on this classic pathway and employed genetic or pharmacological modulation of IKK or IκBα.1, 2, 4–6 These studies did not address the discrete functions of the five NF-κB subunits (RelA, c-Rel, RelB, p50, and p52) that combine to form functionally distinct NF-κB homodimers and heterodimers.7

Gene knockout mice exist for all five NF-κB subunits and reveal nonoverlapping functions.7 For example, relA−/− is embryonic lethal due to profound loss of hepatocyte survival mechanisms during embryogenesis.8 The other subunit knockouts are all viable with no obvious liver dysfunction. However, specific immunological and hematological defects are documented for mice deficient in c-rel, relB, nfkb1 (p50), and nfkb2 (p52), raising the possibility of influences on wound-healing responses in the liver.7, 9–12 In support of this, nfkb1−/− mice are susceptible to hyperinflammatory and fibrogenic responses in the liver.13, 14

NF-κB complexes containing c-Rel are mainly found in hematopoietic cells; however, c-Rel is expressed in a variety of cell types and organs at varying levels.15 Mice deficient in c-rel display multiple immunological abnormalities including proliferative and functional defects in mature B and T cells, as well as aberrant expression of cytokines and cell survival factors.9, 16 c-Rel is essential for dendritic cell (DC) maturation and for their ability to stimulate T cell responses.17 DCs and macrophages lacking c-Rel display defects in expression of interleukin-12, with production of the p35 subunit defective in DCs and expression of p40 defective in macrophages.18, 19 Functions for c-Rel outside of the immune system are emerging with overexpression, amplification, or rearrangement of the human gene reported for solid tumors.20 To date, hepatic functions of c-Rel in either normal or pathological conditions have not been investigated.

In this study, we show that c-Rel is expressed in the adult mouse liver and we report defects in the hepatic inflammatory, wound-healing, and regenerative responses of c-rel−/− mice, thus revealing a previously unrealized function for c-Rel as an orchestrator of the healing response of the damaged liver.

Materials and Methods

  1. Top of page
  2. Abstract
  3. Materials and Methods
  4. Results
  5. Discussion
  6. References
  7. Supporting Information

Animal Models.

c-rel−/− mice were backcrossed nine times to a pure C57BL/6 background.21 Male mice (25–30 g) were intraperitoneally injected once (acute) or twice weekly for 12 weeks (chronic) with CCl4 at 1 μL/g body weight (CCl4:olive oil at 1:1 [vol/vol] and 1:3 [vol/vol] [chronic]). Partial hepatectomy (PHx) was performed by removal of 70% of the liver, and sham-operated animals were used as controls. PHx mice were injected intraperitoneally with 100 mg bromodeoxyuridine (BrdU)/kg body weight, 2 hours before culling. Bile duct ligation (BDL) was performed by exposing the bile duct and double-ligating it, then cutting through between the ligations. Mice were then allowed to develop cholestatic disease and fibrosis over a period of 21 days. All animals received humane care according to the criteria outlined in the “Guide for Care and Use of Laboratory Animals”.

Western Blotting and Enzyme-Linked Immunosorbent Assay.

Sodium dodecyl sulfate polyacrylamide gel electrophoresis and immunoblotting was performed on 50 or 200 μg whole liver protein as previously described.13 Antibodies tested are listed in Supporting Table 1. RANTES (Regulated upon Activation, Normal T-cell Expressed, and Secreted; also known as CCL5) protein was measured using a mouse RANTES immunoassay (Quantikine; R&D Systems, Minneapolis, MN) and 125 μg of whole liver protein extract.

Immunohistochemistry and Densitometry.

Deparaffinized-sections were incubated in hydrogen peroxide/methanol. Alpha-smooth muscle actin (α-SMA) staining was performed as described.13 For antigen retrieval, sections were incubated at 37°C in 0.0005% trypsin–ethylene diamine tetraacetic acid (proliferating cell nuclear antigen [PCNA], BrdU) or 0.01% pronase (CD68, neutrophil marker [NIMP]) in phosphate-buffered saline for 20–30 minutes. Sections were blocked using avidin/biotin (Vector) and blocking serum (Sigma) for 20 minutes each. Antibodies tested are listed in Supporting Table 1. Sections were hematoxylin counterstained. Liver slides were blinded, and random fields were counted by two researchers in twenty 400× magnification areas. Image analysis was performed using Leica Qwin.

Isolation of Hepatocytes and Hepatic Stellate Cells.

Livers were perfused with Earle's Balanced Salt Solution minus Ca2+/Mg2+ (EBSS; Gibco) with 500 μM ethylene glycol tetraacetic acid, then EBSS without Ca2+/Mg2+ only, and finally EBSS with Ca2+/Mg2+ and 0.05% (wt/vol) collagenase A (all solutions at 37°C). Digested livers were filtered through nybolt and the cells collected by centrifugation (50 g for 3 minutes) and washed twice in EBSS. Hepatocytes were cultured in William's medium E (WME; Gibco) supplemented with 10% fetal bovine serum. Hepatic stellate cells (HSCs) were isolated and cultured as described.13

Isolation of Total RNA and Real-Time Reverse Transcription Polymerase Chain Reaction.

RNA was isolated using the RNeasy Mini Kit (Qiagen) following the manufacturer's instructions. Reverse transcription was performed as previously described.13 Real-time polymerase chain reaction (PCR) was based on SYBR-Green. Primer sequences are included in Supporting Table 2.

Tritiated Thymidine Incorporation Assay.

Freshly isolated hepatocytes were seeded in a 96-well plate at 6 × 104 cells/well in 100 μL WME containing 10% fetal bovine serum. After 5 hours, medium was replaced to serum-free WME. After 24 hours of serum-starvation, cells were pulsed with 0.5 μCi [3H]thymidine (Amersham) and incubated for 18–20 hours. To quantify [3H]thymidine incorporation, cells were harvested and measured by scintillation counter.

ChIP Assay.

Chromatin immunoprecipitation (ChIP) assays were carried out as described in the Supporting Materials and Methods text using the mouse-specific primers forkhead box M1 (FoxM1) cRel Ch1F = 5′-GCC ACG TAA CCG CAA GTC TA-3′ and FoxM1 cRel Ch1R = 5′-TCA GTG GTC GAC TTC CTT CC-3′.

Statistical Analysis.

Data are expressed as means ± standard error of the mean (SEM). All P values were calculated using a two-tailed paired or unpaired Student t test. Statistically significant data is represented in figures where *, **, and *** denote P values of < 0.05, < 0.01, and < 0.001, respectively.

Results

  1. Top of page
  2. Abstract
  3. Materials and Methods
  4. Results
  5. Discussion
  6. References
  7. Supporting Information

Defective Hepatic Inflammatory Responses in Injured c-rel−/− Mice.

Western blot confirmed hepatic expression of c-Rel in adult wild-type (Wt) C57BL/6 male mice and absence of expression in c-rel−/− mice (Fig. 1A). Repeated administration of carbon tetrachloride (CCl4) induces hepatic inflammation and fibrosis which resolve upon removal of injury.22 Wt and c-rel−/− mice injured for 12 weeks with CCl4 were culled at days 1, 3, 7, and 10 following final administration of CCl4 so as to analyze pathology at peak injury (day 1) and during recovery (days 3-10). Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) confirmed similar levels of liver injury between Wt and c-rel−/− mice at day 1, which declined to control levels by day 3 (Supporting Fig. 1). Immunohistochemistry for the neutrophil marker NIMP revealed a marked defect in the neutrophilic response of c-rel−/−; at peak injury there were 60% less neutrophils in the injured knockout liver compared with Wt (Fig. 1B,C). Similar numbers of neutrophils were detected in the spleen of Wt and c-Rel–deficient mice, indicating normal neutrophil production in c-rel−/− mice (Fig. 1B,D). We additionally observed a trend toward reduced numbers of macrophages (CD68+) in c-rel−/− livers; however, differences did not reach statistical significance (Supporting Fig. 2).

thumbnail image

Figure 1. Deficiency of c-Rel attenuates chronic inflammation. (A) Western blot analysis of c-Rel in whole liver protein extracts from three Wt or c-rel−/− mice. (B) Representative images of liver (upper panel) and spleen sections (lower panel) immunostained for detection of neutrophils (anti-NIMP) at peak injury (day 1 after final CCl4 administration of a 12-week chronic injury model). Bar = 50 μm (liver) and 20 μm (spleen). (C) Manual counts for neutrophils in livers at peak injury (day 1) and recovery (day 3–10). (D) Neutrophil-positive area in anti-NIMP immunostained spleen sections at peak injury (day 1). Counts performed as described in Materials and Methods. Data are mean ± SEM, n = 5. Paired t test NIMP day 1, P = 0.0009.

Download figure to PowerPoint

RANTES has previously been reported to be regulated by c-Rel.23 Mice that overexpress RANTES revealed a preferential role for the chemokine in the recruitment of neutrophils.24 We therefore investigated if deficiency of c-Rel is associated with attenuated induction of RANTES. In Wt mice, peak injury (day 1 following final CCl4 injection) was associated with increased RANTES expression (Fig. 2A). With recovery, there was a gradual decline in RANTES transcript, reaching baseline levels by day 10. RANTES transcript was found at reduced levels in the livers of uninjured (olive oil control) and at a peak in injured in c-rel−/− mice. These RANTES defects were also observed by enzyme-linked immunosorbent assay on whole liver protein extract (Fig. 2B). A single administration of CCl4 provides a model for acute resolving inflammation. With this model, we observed defective neutrophil recruitment at 24 hours after injury in c-rel−/− livers (Fig. 3A,B), which was associated with reduced expression of RANTES transcript compared to Wt (Fig. 3C). Of note, higher serum ALT and AST levels were observed in acute injured c-rel−/− mice, suggesting an increased susceptibility to liver damage that was somehow compensated for in chronic injury (Supporting Fig. 3).

thumbnail image

Figure 2. Chemokine expression defects in c-rel−/− livers. (A) Quantitative reverse transcription PCR (qRT-PCR) detection of RANTES transcript expression from whole liver messenger RNA (mRNA) at 1, 3, 7 and 10 days after final CCl4 injury of a chronic injury model (n = 5–6). (B) ELISA quantification of RANTES in whole liver protein extracts (n = 5). Data are mean ± SEM. Unpaired t test for RANTES mRNA in: olive oil, P = 0.0053; day 1, P = 0.0216; day 3, P = 0.0009. Unpaired t test for RANTES protein in: olive oil, P = 0.0011; day 1, P = 0.0049; day 3, P = 0.0155.

Download figure to PowerPoint

thumbnail image

Figure 3. Attenuated acute hepatic inflammatory response in c-rel−/− mice. Mice were injured by a single intraperitoneal administration of CCl4 and culled 4, 12, 24, and 48 hours later. (A) Representative images of liver sections immunostained for detection of neutrophils. Bar = 50 μm. (B) Manual counts of NIMP+ neutrophils. (C) qRT-PCR detection of RANTES. Data are means ± SEM, n = 3. Paired t test for NIMP at 24 hours, P = 0.016, and RANTES mRNA at 24 hours, P = 0.0132.

Download figure to PowerPoint

The Fibrogenic Response to Injury Is Attenuated by Deficiency of c-Rel.

Chronic CCl4 injury provokes activation of HSCs which adopt an α-SMA+ myofibroblastic phenotype characterized by expression of type I collagen and the matrix metalloproteinase inhibitor tissue inhibitor of metalloproteinase 1 (TIMP-1).22 Persistence and proliferation of myofibroblasts leads to the formation of tracts of fibrotic matrix that bridge vessels and thicken as the fibrotic reaction matures. Chronic injury of C57BL/6 mice led to advanced fibrosis (fibrosis scoring 3 on Sirius red–stained sections) associated with highly elevated numbers of α-SMA+ HSCs at peak injury (day 1) (Fig. 4A,B). Both the grade of fibrosis (score 2) and numbers of α-SMA–positive cells were reduced for c-rel−/− mice. Quantification of Sirius red staining by densitometric analysis confirmed a significantly reduced level of collagen deposition at peak injury in c-rel−/− compared to Wt livers (Fig. 4B). BDL-induced fibrosis was also attenuated in c-rel−/− mice (Fig. 5A) with reduced collagen deposition again being confirmed by densitometric analysis (Fig. 5B). The observation of reduced fibrosis in both the CCl4 and BDL models indicates an important and previously unreported role for c-Rel in fibrogenesis. Activation of HSCs and fibrogenesis is influenced by the inflammatory response25 and RANTES, which are both defective in c-rel−/− livers and may therefore partly explain the attenuated fibrosis. However, we also observed intrinsic differences in the phenotype of in vitro culture-activated c-rel−/− HSCs, with reduced expression of collagen I (Fig. 5C), suggesting a direct influence of c-Rel on fibrogenesis. We also observed a trend toward reduced expression of α-SMA in c-rel−/− HSCs, although this did not reach statistical significance. Of note, levels of TIMP-1 were similar between Wt and c-Rel–deficient HSCs. These data suggest selective influences of c-Rel on fibrogenic gene expression and that the decreased fibrosis observed in injured c-rel−/− mice may primarily be due to reduced collagen expression, despite similar levels of TIMP-1.

thumbnail image

Figure 4. Attenuated hepatic fibrogenesis in chronic CCl4-injured c-rel−/− mice. (A) Top panels are representative picosirus red–stained liver sections for detection of cross-linked collagen I/III at peak fibrosis. Bar = 100 μm. Lower panels are representative images of liver sections stained for α-SMA. (B) Upper graph shows pathology grading for liver fibrosis (4 = cirrhosis, 0 = normal) comparing Wt and c-rel−/− livers at peak injury (day 1) and during recovery (days 3 to 10) from chronic injury. Middle graph shows fibrosis densitometry of Sirius red–stained sections. Lower graph shows manual counts for α-SMA+ cells at each time point (n = 5). Data are mean ± SEM. Paired t test fibrosis grading day 1, P = 0.048; fibrosis densitometry day 1, P = 0.0459; unpaired t test α-SMA day 1, P = 0.027.

Download figure to PowerPoint

thumbnail image

Figure 5. Attenuated hepatic fibrogenesis in BDL c-rel−/− mice. (A) Representative picrosirius red–stained liver sections of Wt and c-rel−/− mice (n = 5–6). Bar = 100 μm. (B) Fibrosis densitometry of Sirius red–stained sections. (C) Quantitative RT-PCR analysis of collagen I, α-SMA, and TIMP-1 expression in cultures of HSCs derived from Wt and c-rel−/− livers (n = 3). Data are mean ± SEM. Unpaired t test fibrosis densitometry, P = 0.0095, and for collagen mRNA, P = 0.015.

Download figure to PowerPoint

Hepatocyte Regeneration Requires c-Rel.

Toxic injury of the liver is associated with loss of hepatocytes that triggers compensatory hepatocyte proliferation.26 Proliferating hepatocytes were detected in chronic CCl4-injured livers using antibodies recognizing PCNA and by hematoxylin counterstaining to visualize mitotic bodies (Fig. 6A). The proliferative markers were most abundant at day 3 after injury, indicating a burst of replicative activity occurs during the early phase of recovery from fibrotic disease (Fig. 6B). The c-Rel–deficient livers displayed low numbers of PCNA-positive hepatocytes, indicating a defect in hepatocyte DNA synthesis. The “gold standard” model for study of hepatocyte regeneration is partial hepatectomy (PHx) which induces synchronized compensatory hepatocyte proliferation in the remnant liver.27 BrdU and PCNA were widely detected at 36 hours after PHx in Wt hepatocytes and were 14-fold and 4-fold lower, respectively, in c-rel−/− livers at this time point (Fig. 7A). This dramatic effect on hepatocyte DNA synthesis was associated with a modest reduction in recovery of liver mass at 72 hours (Supporting Fig. 4). FoxM1B (FoxM1) is a transcription factor that is essential for normal mitosis in the regenerating liver.28 Regeneration in Wt liver was associated with a sharp peak of FoxM1 transcript expression at 36 hours after PHx (Fig. 7B). FoxM1 expression was blunted in c-rel−/− livers at 36 hours, but slightly elevated compared to Wt at 72 hours, suggesting a requirement of c-Rel for appropriate timing of FoxM1 expression during regeneration. ChIP analysis using chromatin prepared from sham-operated liver revealed an absence of c-Rel binding at the FoxM1 promoter (Fig. 7C). However, induced c-Rel binding at the FoxM1 promoter was observed at both 24 and 36 hours after hepatectomy (Fig. 7C), with a 25-fold induction at the latter time point, which coincided with maximal expression of FoxM1 transcript (Fig. 7B). FoxM1 is therefore a direct target for c-Rel but only in response to injury/regeneration. Subsequent targets for transcriptional stimulation of DNA replication by FoxM1 are cyclin B1 and Cdc25C.29 In Wt livers, cyclin B1 and Cdc25C transcripts were induced at 36 hours after PHx and expression subsequently declined at 72 hours (Fig. 7D). Induction of cyclin B1 and Cdc25C was suppressed by 50% in c-rel−/− livers at 36 hours but displayed a subsequent rise in expression peaking at 72 hours to levels observed in Wt mice at the earlier 36-hour time point. Lower expression of cyclin B1 in c-rel−/− versus Wt livers at 36 hours was confirmed at the protein level by western blot (Fig. 7E). We also detected raised levels of cyclin-dependent kinase inhibitor p21Cip1 (p21) in c-rel−/− livers (Fig. 7E). The sustained expression of p21 in c-rel−/− livers resembles data from PHx studies with Foxm1b−/− mice where sustained expression of p21 resulted in decreased activation of Cdk2 kinase.28 To determine hepatocyte function for c-Rel, we established primary hepatocyte cultures from Wt and c-rel−/− livers and determined their baseline (Fig. 8A) and epidermal growth factor–stimulated (Fig. 8B) rates of hepatocyte DNA synthesis, both of which were reduced in c-rel−/− hepatocytes. Western blot analysis of FoxM1 expression was also consistently lower in cultured c-rel−/− hepatocytes compared to Wt (Fig. 8C). These data suggest a function for c-Rel in the control of hepatocyte FoxM1 expression and in the regulation of hepatocyte DNA synthesis.

thumbnail image

Figure 6. Deficiency of c-Rel has a suppressive influence on hepatocyte mitosis. (A) Representative liver sections from chronic CCl4-injured livers stained for PCNA (top) and hematoxylin (bottom). Bars are 100 μm (PCNA) and 20 μm (hematoxylin; inset = 10 μm). (B) Manual counts of PCNA+ cells and mitotic bodies (hematoxylin stains), comparing Wt and c-rel−/− livers at peak injury (day 1 after the final injection) and with recovery (days 3–10). Data are mean ± SEM, n = 5. Paired t test PCNA day 3, P = 0.0401; mitotic bodies day 3, P = 0.0190.

Download figure to PowerPoint

thumbnail image

Figure 7. Dysfunctional hepatocytes lower the regenerative response in c-rel−/− livers. (A) Top left graph is the determination of DNA synthesis (BrdU+) in hepatocytes at various time points up to 120 hours following PHx. Top right graph is a comparison of proliferating hepatocytes by manual counts of PCNA+ hepatocytes (n = 3–5 mice per group). (B) Expression of transcripts for FoxM1B in whole liver (n = 3–5). (C) FoxM1 promoter ChIP analysis on genomic DNA extracted from PHx livers (24 and 36 hours). (D) Transcript levels of cyclin B1 and Cdc25C in whole liver (n = 3–5). (E) Western blot analysis of cyclin B1 and p21 in three Wt and three c-rel−/− livers, with protein loading controlled by β-actin expression. Data are mean ± SEM. Unpaired t test for BrdU at 36 hours, P = 0.030; PCNA at 36 hours, P = 0.0109 and transcript levels of FoxM1 at 36 hours, P = 0.0438; cyclin B1 at 36 hours, P = 0.0286 (Mann-Whitney test). Unpaired t test for ChIP, sham-operated versus 36 hours, P = 0.0107.

Download figure to PowerPoint

thumbnail image

Figure 8. An impaired regenerative response of c-rel−/− hepatocytes. (A) Isolated primary hepatocytes were cultured for 20 hours in the presence of [3H]thymidine and uptake into newly synthesized DNA determined by counts on a luminescence counter. (B) DNA synthesized in cultured hepatocytes in response to epidermal growth factor (0–1000 ng/mL). (C) FoxM1b protein expression in hepatocytes following PHx as determined by western blotting. Protein was analyzed in four different animals per genotype and controlled for loading by β-actin. Paired t test proliferation hepatocytes, P = 0.0387.

Download figure to PowerPoint

Discussion

  1. Top of page
  2. Abstract
  3. Materials and Methods
  4. Results
  5. Discussion
  6. References
  7. Supporting Information

Repair and regeneration of the injured liver requires orchestration of immune, wound-healing, and regenerative responses involving interplay between nonparenchymal and parenchymal cells. We have discovered pleiotropic functions for c-Rel in the hepatic wound-healing response. Absence of c-Rel leads to multiple defects including the appropriate production of RANTES, neutrophil recruitment, the fibrogenic response, and hepatocyte proliferation. We conclude that c-Rel is an important regulator of liver homeostasis via multiple functions in parenchymal and nonparenchymal cells.

Neutrophil recruitment is essential for the innate immune response to injury and is controlled by several different chemokines, including RANTES. Transgenic overexpression of RANTES leads to selective enhanced recruitment of neutrophils following tissue injury. RANTES can also directly target HSCs to promote their proliferation and migration, and mice deficient for RANTES or its receptors chemokine (C-C) motif receptor 1 (CCR1) and CCR5 display substantially reduced fibrosis.30 Here, we show that deficiency of c-Rel is associated with substantially reduced baseline and injury-induced expression of RANTES, which may therefore help explain the reduced numbers of recruited neutrophils, lower numbers of α-SMA+ HSCs, and the attenuated fibrogenic response. However, using the culture model of HSC transdifferentiation, we also discovered inherent defects in c-rel−/− HSCs, specifically reduced expression of collagen I and α-SMA transcripts. NF-κB is a regulator of HSC survival and their expression of inflammatory regulators intercellular cell adhesion molecule-1 and interleukin-6.31 Pharmacological blockade of NF-κB can promote HSC apoptosis and regression of liver fibrosis.32, 33 However, the precise contribution of the individual NF-κB subunits toward the fate and function of HSCs has not been investigated. Our previous report that the p50 subunit is a suppressor of the inflammatory properties of HSC-derived myofibroblasts,13 taken together with the potential for c-Rel to regulate expression of collagen I, α-SMA, and RANTES suggests the need for detailed studies of the functions of the NF-κB subunits in HSCs and fibrosis.

Nonparenchymal cells, including HSCs, can influence liver regeneration through paracrine stimulation of hepatocyte proliferation.34 Defective function of the inflammatory and fibrogenic compartments may therefore contribute to the attenuated DNA synthesis and mitosis of hepatocytes observed in injured and PHx livers of c-rel−/− mice. However, we propose that c-Rel also plays a more direct role as a regulator of hepatocyte DNA replication. B cells deficient in c-Rel display deficiencies in cyclin D3 and cyclin E expression, cyclin-dependent kinase activity, Rb phosphorylation, and E2F activity and fail to progress through the cell cycle in response to B cell receptor stimulation.35 Because ChIP analysis confirmed recruitment of c-Rel to the FoxM1 promoter following PHx, we suggest that c-Rel regulates hepatocyte proliferation via transcriptional control of the cell cycle regulator FoxM1, which following PHx, was not induced at the appropriate time or level of expression in c-Rel–deficient livers. FoxM1 regulates proliferation of many cell types and in the developing liver and heart is essential for normal mitosis.36 Expression profiling identified a cluster of FoxM1-regulated genes including G2/M-specific genes such as cyclin B1 and CENP-F (centromere protein F).37 In particular, transcriptional activation of cyclin B1 by FoxM1 is crucial for timely mitosis.37 Induction of cyclin B1 was delayed in the regenerating c-Rel–deficient liver. FoxM1 expression is repressed in quiescent hepatocytes, but is expressed during liver regeneration and is required for DNA synthesis and mitosis.38 Aberrant induction of FoxM1 following PHx and the associated defects in the expression of cell cycle factors (delayed induction of cyclin B1 and Cdc25C combined with sustained expression of p21) found in regenerating c-rel−/− livers resembles the phenotype described in mice with hepatocyte-targeted disruption of foxm1.38 We conclude that c-Rel is required for appropriate timing of the induction of FoxM1 and exerts a regulatory influence on hepatocyte DNA synthesis during the regenerative response.

Recent work provides conflicting data for the effects of hepatocyte-targeted blockade of NF-κB on proliferative responses to injury and PHx.39-41 These studies employed inducible hepatocyte-selective transgenic expression of a degradation-resistant IκBα transgene or hepatocyte-targeted deletion of IKK2, both of which lead to inhibition of the canonical (RelA/p50) NF-κB pathway. However, functions for IKK2 are emerging outside of the NF-κB system, including influences of proteins intimately associated with cell cycle control.42 Further investigation of distinct NF-κB subunit-specific functions may help better define the role of the NF-κB system in liver homeostasis and regeneration.

In summary, c-Rel may now be considered an important regulator of hepatic wound-healing. Moreover, the potential for c-Rel activities to influence pathological features of the chronic injured liver—including hepatitis, fibrosis, and hepatocellular carcinoma—should be explored.

References

  1. Top of page
  2. Abstract
  3. Materials and Methods
  4. Results
  5. Discussion
  6. References
  7. Supporting Information
  • 1
    Elsharkawy AM, Mann DA. Nuclear factor-κB and the hepatic inflammation-fibrosis-cancer axis. HEPATOLOGY 2007; 46: 590597.
  • 2
    Sun B, Karin M. NF-κB signaling, liver disease and hepatoprotective agents. Oncogene 2008; 27: 62286244.
  • 3
    Hayden MS, West AP, Ghosh S. NF-κB and the immune response. Oncogene 2006; 25: 67586780.
  • 4
    Sakurai T, Maeda S, Chang L, Karin M. Loss of hepatic NF-κB activity enhances chemical hepatocarcingenesis through sustained c-Jun N-terminal kinase 1 activation. Proc Natl Acad Sci U S A 2006; 103: 1054410551.
  • 5
    Luedde T, Beraza N, Kotsikoris V, van Loo G, Nenci A, De Vos R, et al. Deletion of NEMO/IKKγ in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 2007; 11: 119132.
  • 6
    Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 2004; 431: 462466.
  • 7
    Gerondakis S, Grumont R, Gugasyan R, Wong L, Isomura I, Ho W, et al. Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models. Oncogene 2006; 25: 67816799.
  • 8
    Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 1995; 376: 167170.
  • 9
    Köntgen F, Grumont RJ, Strasser A, Metcalf D, Li R, Tarlinton D, et al. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity and interleukin-2 expression. Genes Dev 1995; 9: 19651977.
  • 10
    Weih F, Carrasco D, Durham SK, Barton DS, Rizzo CA, Ryseck RP, et al. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB family. Cell 1995; 80: 331340.
  • 11
    Sha WC, Liou HC, Tuomanen EI, Baltimore D. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 1995; 80: 321330.
  • 12
    Caamaño JH, Rizzo CA, Durham SK, Barton DS, Raventós-Suárez C, Snapper CM, et al. Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J Exp Med 1998; 187: 185196.
  • 13
    Oakley F, Mann J, Nailard S, Smart DE, Mungalsingh N, Constandinou C, et al. Nuclear factor-κB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury. Am J Pathol 2005; 166: 695708.
  • 14
    Campbell SJ, Anthony DC, Oakley F, Carlsen H, Elsharkawy AM, Blomhoff R, et al. Hepatic nuclear factor κB regulates neutrophil recruitment to the injured brain. J Neuropathol Exp Neurol 2008; 67: 223230.
  • 15
    Carrasco D, Weih F, Bravo R. Developmental expression of the mouse c-rel proto-oncogene in hematopoietic organs. Development 1994; 120: 29913004.
  • 16
    Liou H-C, Hsia CY. Distinctions between c-Rel and other NF-κB proteins in immunity and disease. Bioessays 2003; 25: 767780.
  • 17
    Boffa DJ, Feng B, Sharma V, Dematteo R, Miller G, Suthanthiran M, et al. Selective loss of c-rel compromises dendritic cell activation of T lymphocytes. Cell Immunol 2003; 222: 105115.
  • 18
    Grumont R, Hochrein H, O'Keeffe M, Gugasyan R, White C, Caminschi I, et al. c-Rel regulates interleukin 12 p70 expression in CD*(+) dendritic cells by specifically inducing p5 gene transcription. J Exp Med 2001; 194: 10211032.
  • 19
    Sanjabi S, Hoffmann A, Liou HC, Baltimore D, Smale ST. Selective requirement for c-Rel during IL-12 p40 gene induction in macrophages. Proc Natl Acad Sci U S A 2000; 97: 1270512710.
  • 20
    Belguise K, Sonenshein GE. PKCθ promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor α synthesis. J Clin Invest 2007; 117: 40094021.
  • 21
    Liou HC, Jin Z, Tumang J, Andjelic S, Smith KA, Liou ML. c-Rel is crucial for lymphocyte proliferation but dispensible for T cell effector function. Int Immunol 1999; 11: 361371.
  • 22
    Iredale JP. Models of liver fibrosis; exploring the dyamic nature of inflammation and repair in a solid organ. J Clin Invest 2007; 117: 539548.
  • 23
    Liu J, Ma X. Interferon regulator factor 8 regulates RANTES gene transcription in cooperation with interferon regulator factor-1, NF-κB and PU.1. J Biol Chem 2006; 281: 1918819195.
  • 24
    Pan ZZ, Parkyn L, Ray A, Ray P. Inducible lung-specific expression of RANTES: preferential recruitment of neutrophils. Am J Physiol Lung Cell Mol Physiol 2000; 279: L658L666.
  • 25
    Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, et al. Selective depletion of macrophages reveals distinct opposing roles during liver injury and repair. J Clin Invest 2005; 115: 5665.
  • 26
    Maeda S, Kamata H, Luo JL, Leffert H, Karin M. IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005; 121: 977990.
  • 27
    Fausto N, Campbell JS, Riehle KJ. Liver regeneration. HEPATOLOGY 2006; 43( 2 Suppl. 1): S45S53.
  • 28
    Ye H, Holterman AX, Yoo KW, Franks RR, Costa RH. Premature expression of the winged helix transcription factor HFH-11B in regenerating liver accelerates hepatocyte entry into S phase. Mol Cell Biol 1999; 19: 85708580.
  • 29
    Wang X, Quail E, Hung NJ, Tan Y, Ye H, Costa RH. Increased levels of forkhead box M1B transcription factor in transgenic mouse hepatocytes prevent age-related proliferation defects in regenerating liver. Proc Natl Acad Sci U S A 2001; 98: 1146811473.
  • 30
    Seki E, De Minicis S, Gwak GY, Kluwe J, Inokuchi S, Bursill CA, et al. CCR1 and CCR5 promote hepatic fibrosis in mice. J Clin Invest 2009; 119: 18581870.
  • 31
    Hellerbrand C, Jobin C, Iimuro Y, Licato L, Sartor RB, Brenner DA. Inhibition of NF-κB in activated rat hepatic stellate cells by proteasome inhibitors and an IκB super-repressor. HEPATOLOGY 1998; 27: 12851295.
  • 32
    Oakley F, Meso M, Iredale JP, Green K, Marek CJ, Zhou X, et al. Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and recovery from rat liver fibrosis. Gastroenterology 2005; 128: 108120.
  • 33
    Watson MR, Wallace K, Gieling RG, Manas DM, Jaffray E, Hay RT, et al. NF-κB is a critical regulator of the survival of rodent and human hepatic myofibroblasts. J Hepatol 2008; 48: 589597.
  • 34
    Passino MA, Adams RA, Sikorski SL, Akassoglou K. Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR. Science 2007; 315: 18531856.
  • 35
    Hsia CY, Cheng S, Owyang AM, Dowdy SF, Liou HC. c-Rel regulation of the cell cycle in primary mouse B lymphocytes. Int Immunol 2002; 14: 905916.
  • 36
    Korver W, Schilham MW, Moerer P, van den Hoff MJ, Dam K, Lamers WH, et al. Uncoupling of S phase and mitosis in cardiomyocytes and hepatocytes lacking the winged-helix transcription factor trident. Curr Biol 1998; 8: 13271330.
  • 37
    Laoukili J, Kooistra MR, Brás A, Kauw J, Kerkhoven RM, Morrison A, et al. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol 2005; 7: 108110.
  • 38
    Krupczak-Hollis K, Wang X, Kalinichenko VV, Gusarova GA, Wang IC, Dennewitz MB, et al. The forkhead box M1 transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration. Proc Natl Acad Sci U S A 2002; 99: 1688116886.
  • 39
    Iimuro Y, Nishiura T, Hellerbrand C, Behrns KE, Schoonhoven R, Grisham JW, et al. NF-κB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest 1998; 101: 802811.
  • 40
    Chaisson ML, Brooling JT, Ladiges W, Tsai S, Fausto N. Hepatocyte-specific inhibition of NF-κB leads to apoptosis after TNF treatment, but not after partial hepatectomy. J Clin Invest 2002; 110: 193202.
  • 41
    Malato Y, Sander LE, Liedtke C, Al-Masaoudi M, Tacke F, Trautwein C, et al. Hepatocyte-specific inhibitor-of-κB-kinase deletion triggers the innate immune response and promotes earlier cell proliferation during liver regeneration. HEPATOLOGY 2008; 47: 20362050.
  • 42
    Perkins ND. Integrating cell-signalling pathways with NF-κB and IKK function. Nat Rev Mol Cell Biol 2007; 8: 4962.

Supporting Information

  1. Top of page
  2. Abstract
  3. Materials and Methods
  4. Results
  5. Discussion
  6. References
  7. Supporting Information

Additional Supporting Information may be found in the online version of this article.

FilenameFormatSizeDescription
HEP_23385_sm_SupportingFigure1.tif2124KSupporting Fig. 1. Deficiency of c-Rel has no effect on the extent of chronic liver damage. Serum markers for liver damage (ALT and AST) in mice treated with CCl4 for 12 wks. Serum was collected on days 1, 3, 7 and 10 after the final injection. Data are mean +/− SEM, n=5-6. ALT/AST values between c-rel−/− and Wt mice are not statistically significant (ns).
HEP_23385_sm_SupportingFigure2.tif8503KSupporting Fig. 2. Deficiency of c-Rel does not influence macrophage levels. Representative images and manual counts of CD68 immunostained liver sections to detect macrophages from mice treated with CCl4 twice weekly for 12 wks (A+B). Bar = 50μm. Manual count of F4/80 immunostained liver sections to detect macrophages from mice treated with a single injection of CCl4 (Abcam, 1:100, mouse monoclonal). Macrophage levels between c-rel−/− and Wt livers are not statistically significant (ns) at each time point analysed in the chronic and acute CCl4 model.
HEP_23385_sm_SupportingFigure3.tif2125KSupporting Fig. 3. Deficiency of c-Rel enhances the extent of acute liver damage. Serum markers for liver damage (ALT and AST) in mice treated with a single injection of CCl4. Serum was collected 4, 12, 24 and 48 hrs later. Data are mean +/− SEM, n=6-8. Unpaired t-test ALT 24 hrs, P = 0.0167; AST levels are not statistically significant (ns).
HEP_23385_sm_SupportingFigure4.tif6371KSupporting Fig. 4. Liver to body weight ratios after partial hepatectomy. Data are mean +/− SEM, n=3-5. Liver to body weight ratios after PHx between c-rel−/− and Wt mice are not statistically significant (ns) at all analysed time points.
HEP_23385_sm_SupportingTable1.tif2124KSupporting Table 1. Summary of all antibodies used in Western blot analysis and immunohistochemistry.
HEP_23385_sm_SupportingTable2.tif2124KSupporting Table 2. Primer sequences for the different genes analysed in this study in SYBR green based real-time PCR.
HEP_23385_sm_SupportingDocument.doc36KSupporting Information

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.